# OnCo record cd30-expression (biomarker). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/biomarkers/cd30-expression/>
  a schema:MedicalTest ;
  onco:kind "biomarker" ;
  schema:identifier "cd30-expression" ;
  schema:name "CD30 expression (CD30-positive)"@en ;
  schema:alternateName "CD30-positive"@en, "CD30+"@en, "CD30 expression"@en, "CD30-expressing"@en, "CD30 IHC"@en ;
  schema:description "CD30 is the antigen of Hodgkin Reed-Sternberg cells and anaplastic large cell lymphoma. Brentuximab vedotin is labelled for Hodgkin lymphoma without a CD30 test and for peripheral T-cell lymphomas that express it."@en ;
  schema:url <https://onco.cc/biomarkers/cd30-expression/> ;
  schema:dateModified "2026-09-23"^^xsd:date ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3904f8dd-1aef-3490-e48f-bd55f32ed67f> ;
  onco:tag "biomarker", "surface-antigen" ;
  onco:related <https://onco.cc/biomarkers/cd19-expression/> ;
  onco:cancers <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/peripheral-t-cell-lymphoma/>, <https://onco.cc/cancers/cutaneous-t-cell-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/brentuximab-vedotin/> ;
  onco:terms <https://onco.cc/terms/ihc/> .